Intco Medical Technology Co Ltd
SZSE:300677

Watchlist Manager
Intco Medical Technology Co Ltd Logo
Intco Medical Technology Co Ltd
SZSE:300677
Watchlist
Price: 65.66 CNY 9.69% Market Closed
Market Cap: ¥43B

Intrinsic Value

The intrinsic value for Intco Medical Technology Co Ltd (300677) under the Base Case is 18.98 CNY. Compared with the current market price of 65.66 CNY, the stock appears Overvalued by 71%.

Based on two methods:

Both DCF and multiples point to overvaluation.

Intrinsic Value
18.98 CNY
Overvaluation 71%
Intrinsic Value
Price ¥65.66
Base Case Scenario
Get notified when the price drop
Track Buy Zone
20% below Intrinsic Value ¥15.19
Get notified when the price drops into your buy zone
Current Price ¥65.66
Intrinsic Value ¥18.98
Margin of Safety 20% ¥15.19
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about Intco Medical Technology Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Intco Medical Technology Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Intco Medical Technology Co Ltd.

Explain Valuation
Alternatives to Intco Medical Technology Co Ltd

Wall St
Price Targets

Dividends

Shareholder Yield

Competitive Landscape

What is the Intrinsic Value of one Intco Medical Technology Co Ltd stock?

The intrinsic value for Intco Medical Technology Co Ltd (300677) under the Base Case is 18.98 CNY.

Is Intco Medical Technology Co Ltd stock undervalued or overvalued?

Compared with the current market price of 65.66 CNY, the stock appears Overvalued by 71%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett